Medications for Hiv Infections

9 results
  • Apretude

    (Cabotegravir)
    ViiV Healthcare Company
    Usage: APRETUDE is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk. A negative HIV-1 test must be confirmed before starting APRETUDE.
  • Descovy

    (emtricitabine and tenofovir alafenamide)
    Gilead Sciences, Inc.
    Usage: DESCOVY is indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥35 kg) in combination with other antiretroviral agents. It is also approved for HIV-1 pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (≥35 kg), excluding those at risk from receptive vaginal sex.
  • Rebel Distributors Corp
    Usage: Isoniazid is indicated for treating all forms of tuberculosis caused by susceptible organisms and for preventive therapy in at-risk groups, including individuals with HIV, close contacts of infectious tuberculosis patients, recent converters, and those with specific medical conditions or residing in high-incidence populations.
  • Marlex Pharmaceuticals Inc
    Usage: Isoniazid is indicated for treating all forms of tuberculosis caused by susceptible organisms and as preventive therapy for at-risk groups, including HIV-positive individuals, close contacts of infected persons, recent converters, and those with certain medical conditions or fibrotic lesions suggesting old tuberculosis.
  • Chartwell RX, LLC
    Usage: Isoniazid oral solution is indicated for treating all forms of susceptible tuberculosis, requiring multi-drug therapy to prevent resistance. It is also used for preventive therapy in high-risk groups, including HIV-infected individuals and close contacts of infectious cases, among others, to reduce tuberculosis incidence.
  • Blenheim Pharmacal, Inc.
    Usage: Isoniazid is indicated for the treatment of all forms of susceptible tuberculosis, requiring combination therapy for active cases. It also serves as preventive therapy for high-risk groups, including HIV-infected individuals, close contacts of infected persons, recent converters, and those with specific medical conditions or living in high-incidence areas.
  • REMEDYREPACK INC.
    Usage: Isoniazid tablets are indicated for the treatment of all forms of tuberculosis caused by susceptible organisms, requiring multi-drug regimens. Additionally, they are used for preventive therapy in high-risk groups, including individuals with HIV, close contacts of TB patients, and others with specific medical conditions related to increased TB risk.
  • VersaPharm Incorporated
    Usage: Isoniazid is indicated for treating all forms of tuberculosis caused by susceptible organisms and for preventive therapy in at-risk groups, including HIV-infected individuals, close contacts of infectious cases, recent converters, and those with specific medical conditions that increase tuberculosis risk.
  • Viracept (nelfinavir mesylate)

    (NELFINAVIR MESYLATE)
    State of Florida DOH Central Pharmacy
    Usage: VIRACEPT is indicated for the treatment of HIV infection in combination with other antiretroviral agents. It has demonstrated efficacy in reducing plasma HIV RNA levels in various clinical studies involving both treatment-naïve and experienced patients.